BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12218957)

  • 1. Interaction of Helicobacter pylori (Hp) and nonsteroidal anti-inflammatory drugs (NSAID) on gastric mucosa and risk of ulcerations.
    Konturek PC; Konturek SJ; Cześnikiewicz M; Płonka M; Bielański W
    Med Sci Monit; 2002 Sep; 8(9):RA197-209. PubMed ID: 12218957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of complications of peptic ulcers in patients with Helicobacter pylori (Hp) infection and/or NSAID use in the era of Hp eradication.
    Bobrzyński A; Beben P; Budzyński A; Bielański W; Plonka M; Konturek S
    Med Sci Monit; 2002 Aug; 8(8):CR554-7. PubMed ID: 12165741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on gastric ulcerogenesis in experimental animals and in humans.
    Pawlik T; Konturek PC; Konturek JW; Konturek SJ; Brzozowski T; Cześnikiewicz M; Plonka M; Bielanski W; Areny H
    Eur J Pharmacol; 2002 Aug; 449(1-2):1-15. PubMed ID: 12163100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development.
    Laine L; Marin-Sorensen M; Weinstein WM
    Am J Gastroenterol; 1992 Oct; 87(10):1398-402. PubMed ID: 1415094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer.
    García-Díaz E; Castro-Fernández M; Romero-Gómez M; Vargas-Romero J
    Rev Esp Enferm Dig; 2002 Dec; 94(12):725-36. PubMed ID: 12733331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
    Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
    Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers.
    Bobrzyński A; Konturek PC; Konturek SJ; Płonka M; Bielański W; Karcz D
    Med Sci Monit; 2005 Mar; 11(3):CR132-5. PubMed ID: 15735566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
    Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of H. pylori infection and NSAIDs in cyclooxygenase-2 mRNA expression in gastric antral, corpus mucosa, and gastric ulcer.
    Wu CY; Wu MS; Chen CJ; Li MC; Lin JT; Chen GH
    J Clin Gastroenterol; 2005 Jan; 39(1):50-5. PubMed ID: 15599211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment--Polish achievements.
    Brzozowski T
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 3():99-126. PubMed ID: 15075467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulcers and gastritis.
    Kashiwagi H
    Endoscopy; 2003 Jan; 35(1):9-14. PubMed ID: 12510220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
    Ji KY; Hu FL
    World J Gastroenterol; 2006 Jun; 12(24):3789-92. PubMed ID: 16804960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori and benign upper digestive disease.
    Lai LH; Sung JJ
    Best Pract Res Clin Gastroenterol; 2007; 21(2):261-79. PubMed ID: 17382276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.